SWVP FUND XIV GP, LLC

Investment decisions are made by the firm's general partner committee, whose members are not publicly disclosed. As a limited liability company, the GP operates under a partnership agreement that delegates authority to designated principals. Without public filings or a firm website, individual names remain undisclosed.

The firm likely makes venture capital or growth equity investments through its fund, SWVP FUND XIV. Typical holdings would be in high-growth sectors such as technology, healthcare, or business services. The specific portfolio companies and stage preferences are not publicly available.

Deal flow is generated through the firm's network of principals, industry contacts, and co-investor relationships. As a private fund GP, it relies on proprietary sourcing and inbound referrals from investment banks and other GPs. Public details on sourcing mechanisms are absent.

No public affiliation with a named parent company or family office is documented. The entity appears as a standalone GP for its fund series. It may share principals with other entities, but this is not confirmed.

The fund likely targets early to growth-stage companies, with a geographic focus on the United States. Sector exposure may include enterprise software, healthcare technology, and other innovation-driven fields. Neither a specific mandate nor exclusions are publicly stated.

It is standard for GP entities to commit a percentage of fund capital alongside limited partners, but SWVP's specific arrangement is not disclosed. Industry norms would see the GP contribute 1-5% of total fund commitments. No public documentation confirms this practice.

It is a Delaware-registered limited liability company structured as a general partner for a private fund. This entity isolates fund liabilities and provides tax pass-through treatment. The structure is standard for closed-end private equity funds.